Conversation
"This stock is deeply discounted. With 2 drugs approved recently, it's become a hot target for acquisition."
Ultragenyx Pharmaceutical is up 6.38% to 101.06
I told you RARE was a BUY at 48.50
Ultragenyx Pharmaceutical is up 8.80% to 125.12
No action at all....options are worthless. CROOKS.
Ultragenyx Pharmaceutical is down 7.12% to 90.50
RARE is up 7.07% to $51.88
This is a 1Bln plus drug and they have the voucher to sell for another $150mm and the mkt gives them a lousy 1.8% pop. Ugh. Wait til u see the price of this drug. and no competition.
RARE reached a new 52 Week Low at 42.60
Ultragenyx Pharmaceutical is up 6.07% to 99.53
Good news and the stock gets destroyed? Anyone have any thoughts on this?
Any one like the collaboration with DSNKY. https://www.daiichisankyo.com/files/news/pressrelease/pdf/202106/20210611_E_47.pdf
Where is Rare's message board - this new Yahoo is POOR
Ultragenyx Pharmaceutical reached a 52 Week high at 80.49
Any real RARE investors left here?
Morgan Stanley raises PT to $175.00 !!!!!
I try this a second time. Saw this stock up $15 AH yesterday afternoon and going into the close today is up 80 cents and that is after reaching a high intra-day of $66 and change. That would be a poster child of #$%$ Biotech stocks. What garbage. LOL
"wow, a lot of price manipulation today."
RARE is down 13.17% to $51.54
Dr Dallas is new CEO for AIMT. Can anyone tell me about him? TIA
RARE is up 5.84% to 77.34
quite a limp d.. response to announcement.
Equity raise announced. Up to 287 million shares. Wow thats alot of shares.
Phase 1/2 Wall Street hype. That is all it is.
RARE is down 6.01% to 51.02
"Better be in S A G E shares or calls on January 1st, 2nd, third, 4th when 90% of mutual funds add it!"
Ultragenyx Pharmaceutical reached a 52 Week high at 119.99
"Another approval. Although small indication for MPSVII. Like GENZ in Gauchier, initial pt est were very low. RARE says 200 pts WW for MPSVII. More likely around 600 pts."
Ultragenyx Pharmaceutical reached a 52 Week high at 71.21
RARE = favorite SMD stock at the
Ultragenyx Pharmaceutical reached a 52 Week high at 73.34
"107 million in ops spending? Big number, increased spending by 37 million, although good pipeline, look for $60+ open and back testing highs in June"
RARE is down 6.63% to 47.89
Ultragenyx Pharmaceutical is up 7.31% to 109.46
new presentation filed. http://files.shareholder.com/downloads/AMDA-2CDCD3/4478728839x0x942982/C81FB4AE-CE1C-4E67-AE99-3A62287ABD46/Ultragenyx_Corporate_Presentation__MAY.pdf
RARE is up 5.94% to $65.46
Not a good investment on rare drug development. Only a few patients to use the drug. How ca it make money? Charge 0.5 m for a pill? Avoid
"Nice recovery from 7% down to being positive now. Results were not bad at all, added more at 44 levels today."
"Is there anybody on this Yahoo board anymore?? where is the conversation? this is reporting week, what is the site for the new message board?"
RARE is down 9.95% to 33.77
Ultragenyx Pharmaceutical is up 6.26% to 102.43
Once again it appears short hedge funds have gained control of Ultragenyx Pharma on low volume. Don't let them steal your shares.
RARE reached a new 52 Week High at 85.14
Ultragenyx Pharmaceutical reached a 52 Week high at 79.24
Ultragenyx Pharmaceutical is up 6.49% to 98.17
Ultragenyx Pharmaceutical reached a 52 Week high at 101.11
RARE is up 6.32% to 82.92
"I've traded RARE many times.I'm not in the shares at present.Yes, I'm aware of the pasting the shares are taking.My thoughts?Very tough decision to make, one way or the other.I wouldn't rule it out, it depends on what comes up.For example, if analysts started coming up with:RARE very compelling at these levels,that would serve as an incentive.From mid80's to current level, that's tough to endure.nt"
Good Volume today… Let's hope it can gain a little momentum.
Ultragenyx Pharmaceutical is down 5.95% to 159.78
RARE reached a 52 Week low at $37.55
Get outta the way shorty! 20 day 'bout to cross the 50 :o).
I am the new format resident west coast intern Yahoo spam assistant. How do you do?
"Except good set of numbers from RARE, improved Revenue and EPS. Credit Suisse has a outperform rating with $67 as price target. Post results we should see $55 !!"
RARE reached a new 52 Week High at 86.99
Ultragenyx Pharmaceutical is down 7.11% to 50.18
RARE has just seen the last of the selling. Looks like a potential push higher with a institutional ownership of 84.90%. google awesomestoc-ks - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
RARE is down -5.26% to 77.34
Some thing is drastically wrong here?????
now what do we do
"go trade, i'm glad the spam is gone!"
"Wow! This crashed from $89.11 Sep 26th to $49.xx on Oct 26th. Nothing but hype as usual. Burning cash, limited revenue, no profit, and probably, the executives are busy lining their pockets despite the trial failure and discontinuation."
Ultragenyx Pharmaceutical is up 8.89% to 115.43
RARE reached a 52 Week low at 35.61
Ultragenyx Pharmaceutical is up 6.19% to 96.89
What's the next big catalyst for RARE. Chart feels like this stock may have put in a bottom already.
RARE is down 5.61% to 57.04
RARE is down -5.98% to 49.08
"This move down seems a bit too big, considering the drug failed a previous Ph2 for Glut1."
RARE is up 5.78% to 52.00
RARE holding STRONGon its mega investment in ARCT
Ultragenyx Pharmaceutical reached a 52 Week high at 69.27
Anyone here have any thoughts about the new neighbor SGMO moving in next door?
"I have been following RARE for last couple of years, when it falls below 60, It bounces back above 75. Hoping to see another pull-back soon.."
RARE is down 9.25% to $38.37
Should hit 55$ tomorrow and then 62$ on back of good results. Expect good revenue this time and positive updates on pipeline
Price action on crl or approval????any guesses???
RARE is down -5.63% to 47.95
Ultragenyx Pharmaceutical reached an all time high at 139.92
"Sweet Diachi Deal for AAV mfg tech. $125MM upfront, Purchase of $75MM in RARE stock at $60 and another $25MM upon completed tech xfer of HeLa PCL and HEK293 mfg platforms. A small single digit royalty is also payable to RARE for products that emerge from the use of the AAV platforms."
Failed but not down . time to recharge and buy
Ultragenyx Pharmaceutical is down 5.59% to 129.98
Poor acquisition on DMTX..
"New offering. Up to $175,000,000 in shares. Wow, not surprised."
Ultragenyx Pharmaceutical reached a 52 Week high at 97.68
Ultragenyx Pharmaceutical reached a 52 Week high at 125.94
Ultragenyx Pharmaceutical reached a 52 Week high at 96.00
Q4 EPS of -$1.89 beats by $0.10 also posted Revenue of $2.41M beats by $2.23M.
From what I see in the swings in price I would never use a market order here.
Ultragenyx Pharmaceutical reached an all time high at 165.90
"no one ever really posted on here anyways, so why do you care which format it's in?"
$RARE Target Lowered by Wedbush Neutral USD 106 » USD 91Target Lowered by Barclays Overweight USD 178 » USD 141
"Beautiful entry point as it closed the gap this morning, heading much higher."
RARE is up 6.36% to 83.65
RARE is up 5.78% to 47.23
I think it's ready to break out. Too many positive catalysts on the way and even the most recent data is not baked into the price yet. Target price: 120.
RARE is down 5.98% to 63.23
"Personally, I am insulted by this valuation."
Is the selling due to the 150M shares being sold to raise funds? This is confusing to rationalize why the pressure to sell. Thanks in advance.
"stock rigged up in front of deal. yet sec has rule you can't short in front of deal if you are involved because they have writte n all companies stock prices go down in front of deals. Guess again. Now that there is novshorting in front of deals the y go up, price high, enrich the basnks underwriting fees, then go down when deal prices hurting mom and pop retail investors. Very sad"
Ultragenyx Pharmaceutical is down 7.56% to 119.14
Ultragenyx Pharmaceutical is up 8.88% to 84.49
Nice to get the upgrade today.
RARE is up 6.46% to 47.97
"BOLD, a gene therapy co, got bought for $3bln. RARE should be at least that mkt. cap, so the stock should be $50+."
RARE is down 8.29% to 46.15
It will be dead money for a long time
RARE is up 6.42% to 56.82
RARE is up 7.39% to 61.77
too much manipulation. No volume even on FDA approval.
Ultragenyx Pharmaceutical reached a 52 Week high at 104.00
"I think what they call this is ""PROFIT TAKING"" before the next leg up. (Jan 9, 2020)"
great news out by SELB so start buying
RARE is up 10.05% to 38.45
SunTrust just released a note stating that a series of strong data catalysts&disruptive medicines being commercialized or entering the clinic they recommend investors being overweight biotech. Their recommendations are:$CRSP $BMRN $CBAY $EDIT $EXEL $INCY$MRTX$RARE $SAGE $SRPT $VKTX $WVEOur time is coming - just be patient.
"One reason to ignore incompetent broker analyst, JPMorgan downgrades RARE from overweight to neutral, sighting earnings went from 1.62 a year ago to .37 this quarter, from everything I see they went from a negative -1.62 to a negative -.37 which was a huge beat as analysist where expecting -1.16. RARE beat in a big way on both sales and earnings!"
Ultragenyx Pharmaceutical is down 5.51% to 83.81
Thank Mr. Trump for todays action
Everyone is up today except RARE!
RARE reached a 52 Week low at 36.33
RARE is presenting at the Goldman conference today at 3:20 PT.
Ultragenyx Pharmaceutical reached an all time high at 148.83
"All this positive news and no movement , anyone care to share their opinion ?"
approved
"Jeffries Downgrade just published, $66.00 PT downgraded to hold."
Ultragenyx Pharmaceutical reached a 52 Week high at 132.12
Ultragenyx Pharmaceutical reached a 52 Week high at 117.22
Ultragenyx Pharmaceutical is down 6.96% to 130.22
"Q1 loosing again a lot of money. RARE looks like a junior miner burning cash at a fast rate, in a tube of drugs for seemingly marginal pacients. Long term, if new subscription of capital is not ready, it will be worth a residue."
RARE is down -5.95% to 80.62
Lean in! There is only one place where you can get awesome free trade alerts. But yuou have to act fast by doing a search for the.stock.dork and drop your email address in that box ASAP! .
good job rare
RARE is up 6.12% to 85.63
RARE is up 11.85% to 48.91
60+ by the end of the day.75+ by the end of the week.85+ by next earnings.
RARE beat 4Q19 and met FY19 EPS estimates. Beat on both 4Q19 rev's and FY19 rev's. Looking for 25-30% crysvita sales incr. for 2020.
"Ultragenyx Pharmaceutical Q4 EPS $(0.37) Beats $(1.16) Estimate, Sales $91.54M Beat $70.54M Estimate"
Ultragenyx Pharmaceutical is up 7.14% to 109.12
Are pharmacy giants circling Ultragenyx Pharmaceutical as a takeover candidate? You may want to keep an eye on this biotechnology gem.
RARE is up 10.62% to 41.34
Ultragenyx Pharmaceutical reached an all time high at 143.77
Ultragenyx $RARE must have known something to invest in $SLDB before the hold was even lifted by FDA
RARE reached a new 52 Week High at 73.42
RARE is down 5.71% to 56.11
DPW is up 5% happy trading
RARE is down 24.87% to 32.56
RARE is down 7.71% to 45.39
RARE is down 5.81% to $75.18
"Nbrv and NTec, biotechs trading at next to nothing insulting levels are the next to go."
RARE reached a new 52 Week High at 78.79
"Ouch x 10000, now what and where do we go from here?"
Ultragenyx Pharmaceutical is up 5.56% to 94.98
Ultragenyx Pharmaceutical is down 7.45% to 129.50
RARE is down -6.64% to 44.98
RARE is down 9.01% to 37.62
Ultragenyx Pharmaceutical reached an all time high at 160.96
"ACE-ER failed, project terminated, will lower burn rate."
Ultragenyx Pharmaceutical is up 6.91% to 143.46
RARE is down 8.20% to 41.63
https://seekingalpha.com/article/4273630-ultragenyx-pharmaceutical-thesis-strengthens-near-term-catalysts-loom?lift_email_rec=false
Is RARE done or is there life left in this. Very disappointing so far. Thanks for any ones thoughts going forward.
Ultragenyx Pharmaceutical is up 5.25% to 84.37
Ultragenyx Pharmaceutical reached a 52 Week high at 115.36
FDA announcement tomorrow.
Ultragenyx Pharmaceutical reached an all time high at 138.50
whose buying this POS?
Ultragenyx Pharmaceutical reached an all time high at 177.66
the new view is useless. just like yahoopoop
Ultragenyx likely to be the next biotech to be acquired by one of the phamaceutical Giants. Looking for a surprise earnings and forecast report this week. Don't overlook this gem.
Looks like all the analysts told their investors to dump after the investor conference day.Cant't tel if this dog can't or won't hunt.
RARE is down 5.54% to 60.56
Looking at an hourly chart it appears a double bottom is in.
Ultragenyx Pharmaceutical is down 5.72% to 94.75
Appears short hedge fund is manipulating share price of Ultragenyx?
RARE reached a 52 Week low at $40.25
RARE is up 6.39% to 49.27
Ultragenyx Pharmaceutical is up 6.55% to 101.79
Motley stool
RARE reached a new 52 Week High at 83.88
Ultragenyx Pharmaceutical reached a 52 Week high at 92.71
Ultragenyx Pharmaceutical is up 6.74% to 94.88
Any Rare investors here ? Just looking for thoughts going forward.
RARE is up 8.47% to $43.24
Ultragenyx Pharmaceutical reached a 52 Week high at 76.81
"I don’t know what I would do without the help of (http://Stocks-tracker.com). Their watchlists are so well researched and help me make the best possible picks when it comes to investing. Not only do they save me time, but their advice has shown to be tried and true!"
"Data from a pediatric mid-stage study evaluating Kyowa Hakko Kirin, $RARE 's Crysvita (burosumab) for the treatment of X-linked hypophosphatemia - a rare, chronic progressive musculoskeletal disorder that affects children and adults - demonstrated that Crysvita improved rickets severity, growth, pain and physical function, and increased serum phosphorus and renal phosphate reabsorption. Here is the link for more info http://crweworld.com/article/news-provided-by-globenewswire/306469/ultragenyx-and-kyowa-kirin-announce-publication-of-phase-2-study-results-demonstrating-that-crysvita-burosumab-improved-outcomes-in-children-with-x-linked-hypophosphatemia-in-the-new-england-journal-of-medici"
Ultragenyx Pharmaceutical reached a 52 Week high at 84.76
"I have no idea what is going on, but I did notice approval of this drug — followed by a yawn from Wall Street. Normally we get a price spike; however, this drug only treats 200 patients worldwide!"
Ultragenyx Pharmaceutical is down 5.95% to 91.60
"DKNG Draftking june calls. You'll thank me, read news"
Ultragenyx Pharmaceutical Inc. is down 13.21% to $147.44
Ultragenyx Pharmaceutical is up 7.40% to 155.66
7200% bounce expected with $KOSK stocks..More deals with pharmaceutical companies expected.
Nice recent moves
"This can of rotten worm be played for years, amazing."
What's it going to take to get this headed in the right direction? Mostly good news and no follow through on share price.
How low can this go? Time to buy?
RARE is down 7.11% to 50.18
didn't any one read how much the insiders bought recently? why isn't this moving higher today?
Ultragenyx Pharmaceutical is down 8.88% to 148.32
what was THAT all about. Up $5 and right back down. Like shutes and ladders.
RARE is up 5.55% to 57.27
RARE is up 9.73% to 37.09
RARE is down -4.91% to 81.12
Oops did it again
rare any comments?
Ultragenyx Pharmaceutical reached a 52 Week high at 99.25
Ultragenyx Pharmaceutical reached an all time high at 170.26
RARE appears to suggest upside opportunity. Ive been struggling with this stock lately. Some of my other trades have been from https://pennystockplatform.blogspot.com/ which are working out pretty well.
Yahoo intern's final project was to change format
"fda approval,but market doesnt approval price!!!"
Ultragenyx Pharmaceutical is down 6.73% to 140.45
RARE reached a 52 Week low at 32.56
Ultragenyx Pharmaceutical is up 6.48% to 100.50
RARE reached a 52 Week low at 32.20
Ultragenyx Pharmaceutical is down 6.04% to 113.39
"FDA to allow NDA submission UX007 in LC-FAOD. This could lead to NDA for Glut-1, which is a larger mkt. Need to see what EU says."
